Carl Walkey

8.3k total citations · 4 hit papers
19 papers, 6.0k citations indexed

About

Carl Walkey is a scholar working on Biomaterials, Oncology and Immunology. According to data from OpenAlex, Carl Walkey has authored 19 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomaterials, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Carl Walkey's work include Nanoparticle-Based Drug Delivery (9 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (5 papers). Carl Walkey is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Immune Cell Function and Interaction (6 papers) and CAR-T cell therapy research (5 papers). Carl Walkey collaborates with scholars based in Canada, United States and Australia. Carl Walkey's co-authors include Warren C. W. Chan, Jonathan B. Olsen, Hongbo Guo, Andrew Emili, H. C. Fischer, Travis L. Jennings, Steven D. Perrault, Qin Dai, Rong Liu and Yoram Cohen and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Carl Walkey

19 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake

2011 1.6k citations Carl Walkey, Jonathan B. Olsen et al. Journal of the American Chemical Society profile →
Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment

2011 1.4k citations Carl Walkey, Warren C. W. Chan Chemical Society Reviews profile →
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design

2009 1.3k citations Steven D. Perrault, Carl Walkey et al. Nano Letters profile →
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles

2014 658 citations Carl Walkey, Jonathan B. Olsen et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Walkey Canada	12	3.3k	2.4k	2.0k	2.0k	889	19	6.0k
Christoffer Åberg Netherlands	24	3.8k 1.1×	2.8k 1.1×	2.7k 1.4×	2.6k 1.3×	893 1.0×	49	7.6k
Martin Lundqvist Sweden	24	2.7k 0.8×	1.7k 0.7×	2.0k 1.0×	2.0k 1.0×	681 0.8×	55	5.8k
Dominic Docter Germany	25	2.6k 0.8×	1.9k 0.8×	1.7k 0.9×	1.8k 0.9×	495 0.6×	36	5.2k
Pablo del Pino Spain	38	2.5k 0.8×	2.8k 1.1×	1.8k 0.9×	2.5k 1.2×	1.3k 1.4×	104	6.4k
Stefaan J. Soenen Belgium	42	2.9k 0.9×	3.0k 1.2×	1.6k 0.8×	3.0k 1.5×	679 0.8×	118	6.8k
Beatriz Pelaz Spain	37	2.3k 0.7×	2.8k 1.1×	1.8k 0.9×	2.7k 1.4×	1.4k 1.6×	102	6.2k
Francesca Baldelli Bombelli Italy	33	4.4k 1.3×	3.0k 1.2×	3.2k 1.6×	2.9k 1.5×	1.0k 1.2×	93	8.8k
Daniel F. Moyano United States	32	1.8k 0.5×	1.8k 0.8×	1.8k 0.9×	1.8k 0.9×	874 1.0×	53	5.0k
Shirley K. Knauer Germany	39	2.4k 0.7×	1.6k 0.7×	3.9k 2.0×	1.6k 0.8×	461 0.5×	150	7.6k
Pilar Rivera Gil Germany	36	2.0k 0.6×	2.5k 1.0×	1.8k 0.9×	3.2k 1.6×	1.7k 1.9×	72	6.8k

Countries citing papers authored by Carl Walkey

Since Specialization

Citations

This map shows the geographic impact of Carl Walkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Walkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Walkey more than expected).

Fields of papers citing papers by Carl Walkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Walkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Walkey. The network helps show where Carl Walkey may publish in the future.

Co-authorship network of co-authors of Carl Walkey

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Walkey. A scholar is included among the top collaborators of Carl Walkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Walkey. Carl Walkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Dowling, Quinton M., Young‐Jun Park, Chelsea N. Fries, et al.. (2024). Hierarchical design of pseudosymmetric protein nanocages. Nature. 638(8050). 553–561. 17 indexed citations

2.

Mortales, Christie, et al.. (2023). NL-201 Upregulates MHC-I Expression and Intratumoral T-cell Receptor Diversity, and Demonstrates Robust Antitumor Activity as Monotherapy and in Combination with PD-1 Blockade. Cancer Immunology Research. 11(7). 1000–1010. 6 indexed citations

3.

Li, Xuefeng, Kristin Huntoon, Yifan Wang, et al.. (2023). Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Molecular Cancer Therapeutics. 23(3). 330–342. 2 indexed citations

4.

Walkey, Carl, et al.. (2021). NL-201, a De Novo Agonist of IL-2 and IL-15 Receptors, Demonstrates Synergistic Antitumor Activity with Anti-PD-1 Checkpoint Inhibitor Therapy in a Preclinical Non-Hodgkin Lymphoma Model. Blood. 138(Supplement 1). 4560–4560. 1 indexed citations

5.

Quijano‐Rubio, Alfredo, Umut Y. Ulge, Carl Walkey, & Daniel‐Adriano Silva. (2020). The advent of de novo proteins for cancer immunotherapy. Current Opinion in Chemical Biology. 56. 119–128. 19 indexed citations

6.

Leung, Isabel, et al.. (2020). Abstract 2222: Engineered variants of Neo-2/15 potently expand CAR-T cells and promote antitumor activity in lymphoma and solid tumor mouse models. Cancer Research. 80(16_Supplement). 2222–2222. 1 indexed citations

7.

Walkey, Carl, et al.. (2020). Abstract 4518: Pre-clinical development of NL-201: A de novo α-independent IL-2/IL-15 agonist. Cancer Research. 80(16_Supplement). 4518–4518. 4 indexed citations

8.

Walkey, Carl, et al.. (2020). 576 NL-201, a de novo IL-2 and IL-15 agonist, demonstrates enhanced in vivo antitumor activity in combination with multiple cancer immunotherapies. Regular and Young Investigator Award Abstracts. A346.1–A346. 1 indexed citations

9.

Liu, Rong, Wen Jiang, Carl Walkey, Warren C. W. Chan, & Yoram Cohen. (2015). Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. Nanoscale. 7(21). 9664–9675. 121 indexed citations

10.

Dai, Qin, Carl Walkey, & Warren C. W. Chan. (2014). Polyethylene Glycol Backfilling Mitigates the Negative Impact of the Protein Corona on Nanoparticle Cell Targeting. Angewandte Chemie. 126(20). 5193–5196. 21 indexed citations

11.

Walkey, Carl, Soumen Das, Sudipta Seal, et al.. (2014). Catalytic properties and biomedical applications of cerium oxide nanoparticles. Environmental Science Nano. 2(1). 33–53. 334 indexed citations

12.

Dai, Qin, Carl Walkey, & Warren C. W. Chan. (2014). Polyethylene Glycol Backfilling Mitigates the Negative Impact of the Protein Corona on Nanoparticle Cell Targeting. Angewandte Chemie International Edition. 53(20). 5093–5096. 320 indexed citations

13.

Albanese, Alexandre, Carl Walkey, Jonathan B. Olsen, et al.. (2014). Secreted Biomolecules Alter the Biological Identity and Cellular Interactions of Nanoparticles. ACS Nano. 8(6). 5515–5526. 221 indexed citations

14.

Walkey, Carl, Jonathan B. Olsen, Fayi Song, et al.. (2014). Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles. ACS Nano. 8(3). 2439–2455. 658 indexed citations breakdown →

15.

Walkey, Carl & Warren C. W. Chan. (2012). ChemInform Abstract: Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment. ChemInform. 43(27). 9 indexed citations

16.

Walkey, Carl, Jonathan B. Olsen, Hongbo Guo, Andrew Emili, & Warren C. W. Chan. (2011). Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake. Journal of the American Chemical Society. 134(4). 2139–2147. 1596 indexed citations breakdown →

17.

Walkey, Carl & Warren C. W. Chan. (2011). Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chemical Society Reviews. 41(7). 2780–2799. 1363 indexed citations breakdown →

18.

Walkey, Carl, Edward A. Sykes, & Warren C. W. Chan. (2009). Application of semiconductor and metal nanostructures in biology and medicine. Hematology. 2009(1). 701–707. 33 indexed citations

19.

Perrault, Steven D., Carl Walkey, Travis L. Jennings, H. C. Fischer, & Warren C. W. Chan. (2009). Mediating Tumor Targeting Efficiency of Nanoparticles Through Design. Nano Letters. 9(5). 1909–1915. 1255 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact